Ubiquitin-specific protease 34 serves as a novel prognostic biomarker through correlating with immune responses and cell proliferation in acute myeloid leukemia
USP34 is an independent prognostic predictor in AML and may contribute to leukemogenesis via intervening immune processes and promoting proliferation.
Authors
- Cuijuan Shi (ORCID: https://orcid.org/0000-0002-1730-4487)
- Zhihui Li (ORCID: https://orcid.org/0000-0003-2447-9645)
Institutions
- Tianjin Medical University General Hospital (CN)
- Civil Aviation University of China (CN)
- Ministry of Education (ME)
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s12672-025-03662-1
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- National Natural Science Foundation of China